tiprankstipranks
Trending News
More News >
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market

Cannara Biotech (LOVFF) Ratios

Compare
11 Followers

Cannara Biotech Ratios

LOVFF's free cash flow for Q1 2026 was C$0.20. For the 2026 fiscal year, LOVFF's free cash flow was decreased by C$ and operating cash flow was C$0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 25Dec 24Dec 23
Liquidity Ratios
Current Ratio
2.70 2.40 2.40 2.50 2.44
Quick Ratio
1.05 1.10 1.10 1.01 0.85
Cash Ratio
0.52 0.42 0.42 0.25 0.20
Solvency Ratio
0.29 0.29 0.29 0.19 0.19
Operating Cash Flow Ratio
0.66 0.59 0.59 0.40 0.26
Short-Term Operating Cash Flow Coverage
2.27 1.54 1.54 1.16 0.91
Net Current Asset Value
C$ 22.41MC$ 15.73MC$ 15.73MC$ 705.36KC$ -10.08M
Leverage Ratios
Debt-to-Assets Ratio
0.20 0.25 0.25 0.31 0.32
Debt-to-Equity Ratio
0.31 0.41 0.41 0.55 0.57
Debt-to-Capital Ratio
0.24 0.29 0.29 0.35 0.36
Long-Term Debt-to-Capital Ratio
0.19 0.22 0.22 0.30 0.33
Financial Leverage Ratio
1.56 1.65 1.65 1.76 1.77
Debt Service Coverage Ratio
1.68 1.33 1.33 1.15 1.40
Interest Coverage Ratio
4.19 5.10 5.10 1.78 2.24
Debt to Market Cap
0.21 0.24 0.24 0.78 0.51
Interest Debt Per Share
0.41 0.49 0.49 0.60 0.57
Net Debt to EBITDA
0.68 0.97 0.97 2.75 2.63
Profitability Margins
Gross Profit Margin
38.59%44.00%44.00%36.44%47.56%
EBIT Margin
18.11%20.29%20.29%10.78%18.91%
EBITDA Margin
24.01%26.26%26.26%18.55%27.54%
Operating Profit Margin
14.08%20.68%20.68%12.33%20.76%
Pretax Profit Margin
15.18%16.86%16.86%5.49%12.13%
Net Profit Margin
10.48%12.18%12.18%7.88%12.13%
Continuous Operations Profit Margin
10.48%12.18%12.18%7.88%12.13%
Net Income Per EBT
69.05%72.26%72.26%143.59%100.00%
EBT Per EBIT
107.84%81.53%81.53%44.49%58.42%
Return on Assets (ROA)
6.79%7.75%7.75%4.16%4.91%
Return on Equity (ROE)
11.63%12.79%12.79%7.32%8.71%
Return on Capital Employed (ROCE)
11.14%16.51%16.51%7.89%9.88%
Return on Invested Capital (ROIC)
7.22%10.86%10.86%7.34%9.41%
Return on Tangible Assets
6.79%7.75%7.75%4.16%4.91%
Earnings Yield
7.20%7.78%7.78%10.51%7.78%
Efficiency Ratios
Receivables Turnover
7.40 7.61 7.61 6.27 5.41
Payables Turnover
5.70 5.42 5.42 26.45 3.38
Inventory Turnover
1.33 1.35 1.35 1.30 0.89
Fixed Asset Turnover
1.27 1.25 1.25 0.96 0.64
Asset Turnover
0.65 0.64 0.64 0.53 0.40
Working Capital Turnover Ratio
2.22 2.43 2.43 2.30 1.92
Cash Conversion Cycle
259.44 251.03 251.03 325.90 370.01
Days of Sales Outstanding
49.31 47.98 47.98 58.21 67.52
Days of Inventory Outstanding
274.16 270.36 270.36 281.49 410.49
Days of Payables Outstanding
64.04 67.31 67.31 13.80 108.00
Operating Cycle
323.48 318.33 318.33 339.70 478.01
Cash Flow Ratios
Operating Cash Flow Per Share
0.22 0.21 0.21 0.12 0.06
Free Cash Flow Per Share
0.12 0.15 0.15 0.04 -0.05
CapEx Per Share
0.10 0.07 0.07 0.08 0.11
Free Cash Flow to Operating Cash Flow
0.53 0.68 0.68 0.30 -0.82
Dividend Paid and CapEx Coverage Ratio
2.13 3.15 3.15 1.43 0.55
Capital Expenditure Coverage Ratio
2.13 3.15 3.15 1.43 0.55
Operating Cash Flow Coverage Ratio
0.60 0.48 0.48 0.22 0.12
Operating Cash Flow to Sales Ratio
0.18 0.19 0.19 0.13 0.09
Free Cash Flow Yield
6.57%8.12%8.12%5.25%-4.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.89 12.86 12.86 9.51 12.86
Price-to-Sales (P/S) Ratio
1.49 1.57 1.57 0.75 1.56
Price-to-Book (P/B) Ratio
1.47 1.64 1.64 0.70 1.12
Price-to-Free Cash Flow (P/FCF) Ratio
15.22 12.31 12.31 19.06 -20.10
Price-to-Operating Cash Flow Ratio
7.89 8.40 8.40 5.73 16.42
Price-to-Earnings Growth (PEG) Ratio
-0.97 0.13 0.13 -1.17 0.07
Price-to-Fair Value
1.47 1.64 1.64 0.70 1.12
Enterprise Value Multiple
6.87 6.93 6.93 6.79 8.29
Enterprise Value
185.96M 195.34M 195.34M 102.95M 130.81M
EV to EBITDA
6.87 6.93 6.93 6.79 8.29
EV to Sales
1.65 1.82 1.82 1.26 2.28
EV to Free Cash Flow
16.88 14.31 14.31 32.03 -29.45
EV to Operating Cash Flow
8.95 9.76 9.76 9.64 24.06
Tangible Book Value Per Share
1.19 1.09 1.09 0.98 0.89
Shareholders’ Equity Per Share
1.19 1.09 1.09 0.98 0.89
Tax and Other Ratios
Effective Tax Rate
0.31 0.28 0.28 -0.44 0.00
Revenue Per Share
1.20 1.15 1.15 0.91 0.64
Net Income Per Share
0.13 0.14 0.14 0.07 0.08
Tax Burden
0.69 0.72 0.72 1.44 1.00
Interest Burden
0.84 0.83 0.83 0.51 0.64
Research & Development to Revenue
<0.01 <0.01 <0.01 0.01 0.02
SG&A to Revenue
0.14 0.12 0.12 0.16 0.19
Stock-Based Compensation to Revenue
<0.01 0.01 0.01 0.02 0.03
Income Quality
1.76 1.53 1.53 1.66 0.78
Currency in CAD